Ketoprofen Ennogen Pharma (Ketoprofen)

Ketoprofen inhibits both COX‑1 and COX‑2 enzymes, blocking the conversion of arachidonic acid to prostaglandins. This reduction in prostaglandin synthesis leads to decreased inflammation, pain signaling, and fever, providing symptomatic relief in a variety of painful and inflammatory disorders.

The appropriate dose of ketoprofen is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and renal or hepatic function. Dosage regimens may vary, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

Safety data for ketoprofen in pregnancy are limited, and it is generally avoided, especially in the third trimester, due to potential fetal risks. While small amounts may be excreted in breast milk, nursing mothers should consult their physician before using ketoprofen.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Both ketoprofen and ibuprofen are non‑selective NSAIDs that reduce pain and inflammation. Ketoprofen often has a longer half‑life, allowing less frequent dosing, and may provide stronger analgesia in some patients. However, both share similar gastrointestinal and cardiovascular risk profiles, so choice depends on clinical response and tolerability.

Ketoprofen should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Ketoprofen is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with meals may reduce gastrointestinal discomfort. Patients should swallow tablets whole and not crush or chew them unless directed by a healthcare professional.

Serious risks include gastrointestinal ulceration or bleeding, renal impairment, hepatic dysfunction, severe skin reactions such as Stevens‑Johnson syndrome, anaphylaxis, and increased cardiovascular events like myocardial infarction or stroke. Patients should be monitored for these events, especially if they have pre‑existing risk factors.

Ketoprofen is contraindicated in individuals with known hypersensitivity to ketoprofen or other NSAIDs, active gastrointestinal ulcer or bleeding, severe heart failure, and those who have had a recent coronary artery bypass graft. Caution is also advised for patients with impaired renal or hepatic function.